de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons80297

Dalal,  M. A.
AG Kimura, Mayumi, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80522

Schuld,  A.
Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80478

Pollmächer,  T.
Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Dalal, M. A., Schuld, A., & Pollmächer, T. (2003). Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects. Molecular Psychiatry, 8, 836-837.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-9F93-5
Abstract
There is no abstract available